Concepedia
8
Publications
879
Citations
H-Index
2019
Active since
Affiliations
Wuhan YZY Biopharma (China)(Current)
Huazhong University of Science and Technology
Tongji Hospital
Zhengzhou University
Zhejiang University
Yongxiang Yan is an author at Wuhan YZY Biopharma (China).
Publications per year
2019–2024
The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1
Ming Yi, Jing Zhang, Anping Li et al. · Journal of Hematology & Oncology · 2021 · 239 citations · Full text
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
Ming Yi, Mengke Niu, Yuze Wu et al. · Journal of Hematology & Oncology · 2022 · 170 citations · Full text
Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers
Ming Yi, Mengke Niu, Jing Zhang et al. · Journal of Hematology & Oncology · 2021 · 167 citations · Full text
Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer
Ming Yi, Yuze Wu, Mengke Niu et al. · Journal for ImmunoTherapy of Cancer · 2022 · 143 citations · Full text
A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells
Shengnan Yu, Jing Zhang, Yongxiang Yan et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 96 citations · Full text
Rows per page
1–5 of 8